SecSonar.com

Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pyxis Oncology, Inc. (PYXS) is a Biotechnology company based in US with a market capitalization of $113.7M. Free cash flow was negative at -$63.5M. This page tracks PYXS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 44 employees · IPO Oct 8, 2021

Valuation

Valuation & price

$2.28 · as of May 17, 2026 · -57.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.13

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.34$3.19$1.04Jul 25Dec 25Jul 26Jul 7, 25$1.14Jul 9, 25$1.17Jul 11, 25$1.16Jul 15, 25$1.16Jul 17, 25$1.17Jul 21, 25$1.13Jul 23, 25$1.18Jul 25, 25$1.25Jul 29, 25$1.14Jul 31, 25$1.12Aug 4, 25$1.10Aug 6, 25$1.05Aug 11, 25$1.04Aug 13, 25$1.07Aug 15, 25$1.23Aug 19, 25$1.20Aug 21, 25$1.32Aug 25, 25$1.39Aug 27, 25$1.36Aug 29, 25$1.28Sep 3, 25$1.47Sep 5, 25$1.91Sep 9, 25$1.83Sep 11, 25$1.86Sep 16, 25$2.05Sep 18, 25$2.32Sep 22, 25$2.17Sep 24, 25$2.17Sep 26, 25$2.14Sep 30, 25$2.22Oct 2, 25$2.25Oct 6, 25$2.47Oct 8, 25$2.91Oct 10, 25$3.70Oct 14, 25$3.23Oct 16, 25$3.35Oct 21, 25$3.58Oct 23, 25$3.38Oct 27, 25$3.39Oct 29, 25$3.31Oct 31, 25$3.56Nov 4, 25$3.90Nov 6, 25$4.04Nov 10, 25$4.77Nov 12, 25$4.37Nov 14, 25$4.36Nov 18, 25$4.72Nov 20, 25$4.53Nov 25, 25$5.34Nov 28, 25$5.19Dec 2, 25$3.91Dec 4, 25$4.32Dec 8, 25$4.18Dec 10, 25$4.29Dec 12, 25$4.30Dec 16, 25$4.00Dec 18, 25$1.73Dec 22, 25$1.19Dec 24, 25$1.11Dec 29, 25$1.06Jan 2, 26$1.15Jan 6, 26$1.30Jan 8, 26$1.45Jan 12, 26$2.06Jan 14, 26$1.99Jan 16, 26$1.76Jan 21, 26$1.66Jan 23, 26$1.63Jan 27, 26$1.64Jan 29, 26$1.56Feb 2, 26$1.53Feb 4, 26$1.51Feb 9, 26$1.37Feb 11, 26$1.35Feb 13, 26$1.30Feb 18, 26$1.37Feb 20, 26$1.42Feb 24, 26$1.48Feb 26, 26$1.52Mar 2, 26$1.47Mar 4, 26$1.49Mar 6, 26$1.37Mar 10, 26$1.55Mar 12, 26$1.53Mar 17, 26$1.62Mar 19, 26$1.54Mar 23, 26$1.42Mar 25, 26$1.43Mar 27, 26$1.31Mar 31, 26$1.46Apr 2, 26$1.48Apr 7, 26$1.46Apr 9, 26$1.61Apr 13, 26$1.71Apr 15, 26$1.71Apr 17, 26$1.66Apr 22, 26$1.88Apr 24, 26$1.90Apr 28, 26$1.70Apr 30, 26$1.70May 4, 26$1.76May 6, 26$2.30May 8, 26$2.74May 12, 26$2.60May 14, 26$2.21May 18, 26$2.02May 20, 26$2.00May 22, 26$1.96May 28, 26$1.78Jun 1, 26$1.79Jun 3, 26$1.70Jun 5, 26$1.78Jun 9, 26$1.70Jun 11, 26$1.67Jun 15, 26$1.74Jun 17, 26$1.90Jun 22, 26$2.13Jun 24, 26$2.17Jun 26, 26$2.77Jul 2, 26$2.63
$1.0452-week range$5.34
Loading valuation history…

Fundamentals

Key fundamentals

$113.7M

Market cap

—

Revenue growth (YoY)

82.8%

Gross margin

-$63.5M

Free cash flow (USD)

-$48.2M

Net debt

Net cash position

6.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$16.1MFY 2025$13.9M
$0$13.9M

Free cash flow by year

2019 → 2025

FY 2019$-2.2MFY 2020$-11.6MFY 2021$-35.9MFY 2022$-95.7MFY 2023$-77.4MFY 2024$-57.9MFY 2025$-63.5M
-$2.2M-$63.5M

Gross margin by year

2024 → 2025

FY 202497.1%FY 202582.8%
97.1%82.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.37)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventSecurities Purchase AgreementJul 2, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventCEO DepartureApr 30, 2026Filing

Questions

Frequently asked questions

What is Pyxis Oncology, Inc.'s market cap?

Pyxis Oncology, Inc. (PYXS) has a market capitalization of $113.7M.

What is PYXS's P/E ratio?

A meaningful P/E ratio is not available for PYXS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PYXS's price-to-book (P/B) ratio?

PYXS trades at 2.13 times book value per share.

When did Pyxis Oncology, Inc. last report earnings?

PYXS last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying PYXS stock?

SEC Form 4 filings show no open-market insider buys at Pyxis Oncology, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

GNLX

Genelux Corporation

$114.7M

ALPS

Alps Group Inc

$121.8M

SEER

Seer, Inc.

$103.9M

MIST

Milestone Pharmaceuticals Inc.

$124.1M

EQ

Equillium, Inc.

$103.2M

SGMO

Sangamo Therapeutics, Inc.

$103.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.